Why does depression screening fail in primary care?

Depression screening fails in primary care because a PHQ-9 field in the workflow is not the same as a patient screened. The form sits inside the Annual Wellness Visit, so the box looks checked. But the patients most likely to be depressed are the ones who never show up to that visit, so the panel is never actually reached.

This is the gap between screening on paper and screening in practice. A health system can add a PHQ-9 to its annual visit template, report a screening "process measure," and pass an audit, while most of its at-risk members are sitting at home, unscreened and unseen. Call it screening theater: the apparatus is in place, the documentation is clean, and the people who need it most are missing from the room.

What does the data actually show about screening rates?

Real-world screening rates are far lower than the workflow suggests. When researchers measured documented depression screening from medical records rather than self-report, only about 4 percent of adult primary care visits included a screen across 2010-2018 data. The PHQ-9 may be in the chart, but it is rarely run.

Even the Annual Wellness Visit, the place screening is supposed to live, does not move the number much. One analysis found depression screening occurred in roughly 10 percent of annual wellness visits, no better than ordinary visits. Some systems do far better after a dedicated push, but the unmanaged baseline is the point: putting a field in a template does not make screening happen, and it certainly does not reach the patients who skip the visit entirely.

Why doesn't a workflow equal screening?

A workflow does not equal screening because screening only happens to patients who attend the visit where the form lives. Depression itself is one of the strongest predictors of missed appointments. The patients with the highest unmet need are systematically the least likely to be in the chair when the PHQ-9 is offered.

This is the structural flaw in visit-based screening. It is reactive: it waits for the patient to arrive. But disengagement, no-shows, and avoidance are symptoms of the very condition you are trying to detect. So the model screens the healthiest, most-engaged slice of the panel and counts the rest as "no opportunity." The result is a screening rate that looks like a coverage problem but is really a reach problem. You cannot screen your way out of it by adding more fields to the visit. You have to go get the patients who are not coming.

Integral Health's own analysis of a multi-practice population found the share of an at-risk panel actually reached by visit-based screening was a small fraction of the whole, directionally consistent with the published rates above. The detail lives in our depression screening gap case study.

What happens to patients after a positive screen?

For many patients, a positive screen leads nowhere. Detecting depression is only the first step, and the system leaks badly at the next one. Studies of large primary care populations find that a substantial share of patients who screen positive never reach a single follow-up contact, let alone an effective course of treatment.

The numbers are stark. In one large study, 68 percent of patients confirmed to have depression did not have at least three follow-up appointments within three months of a positive screen, and 23 percent received no minimal treatment at all. A Veterans Health Administration analysis found only 32 percent of patients got clinical follow-up within three months of screening. A positive PHQ-9 that triggers no managed follow-up is a flag raised and ignored, which can be worse than no flag at all because it creates the documentation of detection without the substance of care.

Why is proactive, between-visit outreach the fix?

Proactive, between-visit outreach fixes the reach problem because it stops waiting for the patient to arrive. Instead of screening only whoever attends the wellness visit, a population-based approach identifies the whole at-risk panel, reaches out directly, screens by phone or message, and routes positive screens straight into managed care.

This is the difference between a passive form and an active program. Outreach finds the no-show, the avoider, and the newly enrolled member who has no visit scheduled. It also closes the second gap: when a screen is positive, outreach hands the patient to a care manager rather than to a referral slip that 60-plus percent never act on. The Collaborative Care Model (CoCM) was built for exactly this, pairing a primary care team with a behavioral care manager and a consulting psychiatrist who manage a panel on a registry, between visits, until patients measurably improve. The screening only matters if something happens after it, and between-visit outreach is what makes something happen.

How does measurement-based care close the loop?

Measurement-based care closes the loop by treating the PHQ-9 as a tracking tool, not a one-time gate. The same instrument used to detect depression is repeated over time on a registry, so the care team can see who is improving, who is stalled, and who needs a treatment change, and act before the patient disappears.

This is what turns a screen into an outcome. Under measurement-based care, every patient with a positive screen has a target score and a follow-up cadence. The registry surfaces anyone trending the wrong way for the psychiatric consultant's weekly caseload review. Nobody falls through because the system is built to notice when they do. Screening detects. Outreach reaches. Measurement-based care is the discipline that holds the panel until depression actually lifts. Together they convert "we screened" into "they got better," which is the only version of screening that counts. See how Integral Health runs this end to end on our technology page.

Frequently Asked Questions

Is putting a PHQ-9 in the annual visit enough to screen for depression?

No. A PHQ-9 field in the visit template only screens patients who attend that visit, and depression itself predicts missed appointments. Documented screening rates in primary care run near 4 percent of visits, so the form being present does not mean the at-risk panel is actually reached or screened.

What percentage of primary care patients are actually screened for depression?

Far fewer than the workflow implies. When measured from medical records rather than self-report, documented depression screening occurred in only about 4 percent of adult primary care visits across 2010-2018, and in roughly 10 percent of Annual Wellness Visits, despite the PHQ-9 being a standard part of the visit template.

What happens after a positive depression screen in primary care?

Often very little. In large studies, most patients who screen positive do not receive adequate follow-up. One found 68 percent lacked three follow-up appointments within three months and 23 percent got no minimal treatment, and a VHA analysis found only 32 percent received clinical follow-up within three months of screening.

How do you close the depression screening gap?

By replacing visit-based screening with proactive, between-visit outreach to the whole at-risk panel, then routing positive screens into the Collaborative Care Model with measurement-based care. This reaches patients who skip visits and tracks them on a registry until their PHQ-9 scores actually improve, instead of stopping at detection.

What is measurement-based care in depression treatment?

Measurement-based care repeats a validated tool like the PHQ-9 on a schedule to track each patient's response over time. A registry surfaces patients who are not improving for the care team and consulting psychiatrist to adjust treatment, closing the loop between detecting depression and actually resolving it.